Biologic predictors of survival in node-negative gastric cancer.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMC 1514693)

Published in Ann Surg on June 01, 2003

Authors

David A Kooby1, Arief Suriawinata, David S Klimstra, Murray F Brennan, Martin S Karpeh

Author Affiliations

1: Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

Articles citing this

Gastric adenocarcinoma: review and considerations for future directions. Ann Surg (2005) 3.83

First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer (2006) 1.53

Lymphangiogenesis and cancer metastasis. J Cell Mol Med (2009) 1.47

Detection and Characterization of Metastatic Cancer Cells in the Mesogastrium of Gastric Cancer Patients. PLoS One (2015) 1.45

Correlation of vascular endothelial growth factor expression with tumor recurrence and poor prognosis in patients with pN0 gastric cancer. World J Surg (2012) 1.41

Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg (2005) 1.41

The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification. Gastric Cancer (2011) 1.27

Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS One (2012) 1.20

Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques. Ann Surg (2006) 1.20

The evaluation of metastatic lymph node ratio staging system in gastric cancer. Gastric Cancer (2012) 1.08

Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer. World J Gastroenterol (2012) 0.97

Multidisciplinary management of gastric and gastroesophageal cancers. World J Gastroenterol (2008) 0.97

Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance. J Cancer Res Clin Oncol (2007) 0.97

Prognostic factors on overall survival in lymph node negative gastric cancer patients who underwent curative resection. J Gastric Cancer (2012) 0.94

Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients. Br J Cancer (2006) 0.94

Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Can J Gastroenterol (2008) 0.90

Gender and ploidy in cancer survival. Cell Oncol (Dordr) (2011) 0.88

Prospective, comparative study for the evaluation of lymph node involvement in gastric cancer: Maruyama computer program versus sentinel lymph node biopsy. Gastric Cancer (2012) 0.84

Risk factors for lymphatic and venous involvement in endoscopically resected gastric cancer. J Gastroenterol (2012) 0.83

Prognostic factors in patients with node-negative gastric cancer: an Indian experience. World J Surg Oncol (2011) 0.83

Does tumor size improve the accuracy of prognostic predictions in node-negative gastric cancer (pT1-4aN0M0 stage)? PLoS One (2014) 0.82

Impact on survival of the number of lymph nodes resected in patients with lymph node-negative gastric cancer. World J Surg Oncol (2015) 0.82

Adenocarcinoma of the stomach: a review. Proc (Bayl Univ Med Cent) (2004) 0.82

Clinical significance of lymphadenectomy in patients with gastric cancer. World J Gastrointest Oncol (2016) 0.79

Prognostic role of host cyclooxygenase and cytokine genotypes in a Caucasian cohort of patients with gastric adenocarcinoma. PLoS One (2012) 0.79

Predictive factors for survival and recurrence rate in patients with node-negative gastric cancer--a European single-centre experience. Langenbecks Arch Surg (2014) 0.79

Value of sentinel lymph node mapping using a blue dye-only method in gastric cancer: a single-center experience from North-East Hungary. Gastric Cancer (2011) 0.78

Vascular invasion as an independent predictor of poor prognosis in nonmetastatic gastric cancer after curative resection. Int J Clin Exp Pathol (2015) 0.77

Relationship between 15-hydroxyprostaglandin dehydrogenase and gastric adenocarcinoma. Ann Surg Treat Res (2014) 0.77

Prediction of liver metastases after gastric cancer resection with the use of learning vector quantization neural networks. Dig Dis Sci (2010) 0.76

The prognostic value of lymph nodes count on survival of patients with node-negative gastric cancer. Oncotarget (2016) 0.75

Survival after Gastrectomy in Node-Negative Gastric Cancer: A Review and Meta-Analysis of Prognostic Factors. Med Sci Monit (2015) 0.75

Lymph vessels: the forgotten second circulation in health and disease. Virchows Arch (2016) 0.75

False-positive findings for tumor markers after curative gastrectomy for gastric cancer. Dig Dis Sci (2007) 0.75

Articles cited by this

Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg (1998) 4.86

Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg (1993) 3.80

Simplified staging for hepatocellular carcinoma. J Clin Oncol (2002) 3.48

Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature. Cancer (1993) 2.90

Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg (2000) 2.05

Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value. Br J Cancer (2001) 1.88

Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery (1995) 1.82

Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years. Ann Surg (2002) 1.79

Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg (2002) 1.66

Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery (2000) 1.55

Factors associated with local breast cancer recurrence after lumpectomy alone: postmenopausal patients. Ann Surg Oncol (2000) 1.44

Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol (2002) 1.40

Perineural invasion by ductal adenocarcinoma of the pancreas. J Surg Oncol (1997) 1.33

Perineural invasion in pancreatic cancer. Pancreas (2002) 1.31

Prognostic factors of node-negative gastric carcinoma: univariate and multivariate analyses. J Am Coll Surg (1997) 1.31

A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet (1986) 1.27

Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer (1996) 1.24

Perineural invasion of carcinoma of the pancreas and biliary tract. Br J Surg (1993) 1.23

Survival in stomach cancer is improving: results of a nationwide population-based Swedish study. Ann Surg (1999) 1.22

Adenocarcinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterology (1989) 1.18

Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J Gastrointest Surg (1999) 1.09

Incidence and prognostic significance of vascular invasion in 529 gastric-cancer patients. Int J Cancer (1991) 1.09

Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence. Dis Colon Rectum (2001) 1.07

Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma. Br J Surg (2002) 1.05

Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer. Am J Surg Pathol (2002) 1.02

Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer. J Surg Oncol (2000) 1.02

Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg (1995) 1.01

Surgical treatment and outcome for node-negative gastric cancer. Surgery (1997) 1.00

Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer. Surgery (1995) 1.00

Potentially curative surgery of colon cancer: the influence of blood vessel invasion. J Clin Oncol (1988) 0.95

Is lymphadenectomy necessary for early gastric cancer? Ann Surg Oncol (1999) 0.89

Neural invasion in gastric carcinoma. J Clin Pathol (1995) 0.86

Outcome of prophylactic radical lymphadenectomy with gastrectomy in patients with early gastric carcinoma without lymph node metastasis. Cancer (2000) 0.86

Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer (2000) 0.85

Articles by these authors

Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (2011) 10.26

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet (2009) 8.69

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol (2005) 8.08

Clinicopathologic correlates of solitary fibrous tumors. Cancer (2002) 5.96

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res (2005) 5.44

Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol (2007) 4.95

Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res (2006) 4.83

Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol (2005) 4.79

An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol (2004) 4.74

Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg (2003) 4.25

Quality of complication reporting in the surgical literature. Ann Surg (2002) 4.21

Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol (2005) 3.99

Solid-pseudopapillary tumor of the pancreas: a surgical enigma? Ann Surg Oncol (2002) 3.96

Pasireotide for postoperative pancreatic fistula. N Engl J Med (2014) 3.84

Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol (2002) 3.60

Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol (2003) 3.56

Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A (2011) 3.51

A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg (2006) 3.34

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol (2009) 3.26

Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg (2006) 3.23

Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg (2003) 3.14

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer (2008) 3.10

Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol (2004) 3.08

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas (2010) 3.00

Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg (2010) 2.99

Electronic synoptic operative reporting: assessing the reliability and completeness of synoptic reports for pancreatic resection. J Am Coll Surg (2010) 2.98

Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg (2004) 2.86

Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. J Natl Cancer Inst (2010) 2.79

Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch (2005) 2.76

A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J (2005) 2.71

Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg (2004) 2.62

Surgical treatment and outcomes of patients with primary inferior vena cava leiomyosarcoma. J Am Coll Surg (2003) 2.54

Adult spermatic cord sarcomas: management and results. Ann Surg Oncol (2003) 2.52

Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg (2002) 2.47

The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas (2010) 2.43

Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res (2002) 2.41

Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol (2002) 2.39

Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg (2005) 2.38

Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods. Am J Surg Pathol (2012) 2.38

Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor. Ann Surg (2007) 2.37

Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol (2002) 2.35

The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery (2002) 2.32

Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. Clin Cancer Res (2003) 2.32

Adult genitourinary sarcoma: the 25-year Memorial Sloan-Kettering experience. J Urol (2006) 2.30

Operative drainage following pancreatic resection: analysis of 1122 patients resected over 5 years at a single institution. Ann Surg (2013) 2.29

Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol (2008) 2.27

The value of splenic preservation with distal pancreatectomy. Arch Surg (2002) 2.27

American Surgical Association Blue Ribbon Committee Report on Surgical Education: 2004. Ann Surg (2005) 2.25

Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg (2012) 2.23

Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg (2007) 2.22

Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg (2005) 2.19

Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol (2003) 2.18

Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci U S A (2007) 2.17

Results after pancreatic resection for metastatic lesions. Ann Surg Oncol (2002) 2.15

The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum. Pancreas (2010) 2.13

Clinically aggressive solid pseudopapillary tumors of the pancreas: a report of two cases with components of undifferentiated carcinoma and a comparative clinicopathologic analysis of 34 conventional cases. Am J Surg Pathol (2005) 2.12

Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. J Am Coll Surg (2007) 2.12

Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study. Ann Surg Oncol (2009) 2.10

Atypical lipomatous tumor/well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations. Ann Surg Oncol (2004) 2.09

Prospective functional voice assessment in patients undergoing thyroid surgery. Ann Surg (2002) 2.08

Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg (2003) 2.05

Conventional hemangiopericytoma: modern analysis of outcome. Cancer (2002) 2.04

Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res (2011) 2.00

Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg (2010) 1.98

The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg (2004) 1.97

Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol (2002) 1.96

Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol (2004) 1.96

Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol (2003) 1.94

Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? Hepatology (2012) 1.94

Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol (2003) 1.92

Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci U S A (2008) 1.92

Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. J Clin Oncol (2002) 1.89

The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy. Ann Surg Oncol (2012) 1.87

Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg (2007) 1.86

Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol (2010) 1.85

Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer? Ann Surg Oncol (2007) 1.84

Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer. Ann Surg Oncol (2004) 1.82

Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer (2002) 1.82

Stabilization of beta-catenin induces pancreas tumor formation. Gastroenterology (2008) 1.81

Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res (2003) 1.81

Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Hum Pathol (2004) 1.80

Defining palliative surgery in patients receiving noncurative resections for gastric cancer. J Am Coll Surg (2004) 1.80

Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. J Clin Oncol (2002) 1.78

Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg (2007) 1.75

Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. Ann Surg Oncol (2011) 1.75